Research Article
BibTex RIS Cite

Tescalcin over-expression increases Keratin 18 and 19 in K562 cells

Year 2022, Volume: 6 Issue: 3, 858 - 862, 29.09.2022
https://doi.org/10.30621/jbachs.1101524

Abstract

Tescalcin (TESC) has been shown to be essential in mammalian cells as a regulator of intracellular Ca2+. Ca2+ is a second messenger functioning in many metabolic pathways as well as in cell differentiation, cell size and the cell cycle. K562 cells over-expressing TESC change their morphology and adopt adherent properties. Considering differences in morphology may have been reflected in changes of the cytoskeleton, we focused on the expression levels of keratins, which are cytoskeletal intermediate filaments in epithelial cells and also expressed in K562. We over-expressed the TESC gene via lentiviral transduction and analyzed keratin 8 (K8), keratin 18 (K18), and keratin 19 (K19) expression.

References

  • 1. Gutierrez-Ford C., Levay K., Gomes A. V., et al. Characterization of tescalcin, a novel EF-hand protein with a single Ca2+-binding site: metal-binding properties, localization in tissues and cells, and effect on calcineurin. Biochemistry 2003; 49; 14553–14565.
  • 2. Mailänder J., Müller-Esterl W. and Dedio J. Human homolog of mouse tescalcin associates with Na(+)/H(+) exchanger type-1. FEBS Lett. 2001;507(3);331-335.
  • 3. Okumura M., Yamakawa H., Ohara O. and Owaribe K. Novel alternative splicings of BPAG1 (bullous pemphigoid antigen 1) including the domain structure closely related to MACF (microtubule actin cross-linking factor). J Biol Chem. 2002. 277(8);6682-6687.
  • 4. Ganani D, Malovitski K, Sarig O, Gat A, Sprecher E, Samuelov L. Epidermolysis bullosa simplex due to bi-allelic DST mutations: Case series and review of the literature. Pediatr Dermatol. 2021; 38(2):436-441.
  • 5. Croce C. M. Oncogenes and Cancer. N Engl J Med 2008; 358;502-511.
  • 6. Jӓrvinen M., Andersson L. C. and Virtanen I., K562 Erythroleukemia cells express cytokeratins 8, 18, and 19 and epithelial membrane antigen that disappear after induced differentiation. J of cellular physiology 1990; 143; 310-320.
  • 7. Omary M. B., Intermediate filament proteins of digestive organs: physiology and pathophysiology. Am J Physiol Gastrointest Liver Physiol 2017; 312; G628-G634.
  • 8. Kim H. J., Choi W. J. and Lee C. H. Phosphorylation and Reorganization of Keratin Networks: Implications for Carcinogenesis and Epithelial Mesenchymal Transition. Biomol Ther (Seoul) 2015; 23(4); 301-312.
  • 9. Baykal-Köse S., Acikgoz E., Yavuz A. S. , Geyik O. G., Ateş H, Sezerman O. U., et al. Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells. PLoS ONE. 2020;15(2).
Year 2022, Volume: 6 Issue: 3, 858 - 862, 29.09.2022
https://doi.org/10.30621/jbachs.1101524

Abstract

References

  • 1. Gutierrez-Ford C., Levay K., Gomes A. V., et al. Characterization of tescalcin, a novel EF-hand protein with a single Ca2+-binding site: metal-binding properties, localization in tissues and cells, and effect on calcineurin. Biochemistry 2003; 49; 14553–14565.
  • 2. Mailänder J., Müller-Esterl W. and Dedio J. Human homolog of mouse tescalcin associates with Na(+)/H(+) exchanger type-1. FEBS Lett. 2001;507(3);331-335.
  • 3. Okumura M., Yamakawa H., Ohara O. and Owaribe K. Novel alternative splicings of BPAG1 (bullous pemphigoid antigen 1) including the domain structure closely related to MACF (microtubule actin cross-linking factor). J Biol Chem. 2002. 277(8);6682-6687.
  • 4. Ganani D, Malovitski K, Sarig O, Gat A, Sprecher E, Samuelov L. Epidermolysis bullosa simplex due to bi-allelic DST mutations: Case series and review of the literature. Pediatr Dermatol. 2021; 38(2):436-441.
  • 5. Croce C. M. Oncogenes and Cancer. N Engl J Med 2008; 358;502-511.
  • 6. Jӓrvinen M., Andersson L. C. and Virtanen I., K562 Erythroleukemia cells express cytokeratins 8, 18, and 19 and epithelial membrane antigen that disappear after induced differentiation. J of cellular physiology 1990; 143; 310-320.
  • 7. Omary M. B., Intermediate filament proteins of digestive organs: physiology and pathophysiology. Am J Physiol Gastrointest Liver Physiol 2017; 312; G628-G634.
  • 8. Kim H. J., Choi W. J. and Lee C. H. Phosphorylation and Reorganization of Keratin Networks: Implications for Carcinogenesis and Epithelial Mesenchymal Transition. Biomol Ther (Seoul) 2015; 23(4); 301-312.
  • 9. Baykal-Köse S., Acikgoz E., Yavuz A. S. , Geyik O. G., Ateş H, Sezerman O. U., et al. Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells. PLoS ONE. 2020;15(2).
There are 9 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Research Article
Authors

Hande Efe 0000-0002-3128-0047

Özge Uysal Yoca 0000-0002-3906-6918

Umut Özerk Önkol 0000-0002-3619-1043

Zeynep Yuce 0000-0002-2762-0942

Publication Date September 29, 2022
Submission Date April 12, 2022
Published in Issue Year 2022 Volume: 6 Issue: 3

Cite

APA Efe, H., Uysal Yoca, Ö., Önkol, U. Ö., Yuce, Z. (2022). Tescalcin over-expression increases Keratin 18 and 19 in K562 cells. Journal of Basic and Clinical Health Sciences, 6(3), 858-862. https://doi.org/10.30621/jbachs.1101524
AMA Efe H, Uysal Yoca Ö, Önkol UÖ, Yuce Z. Tescalcin over-expression increases Keratin 18 and 19 in K562 cells. JBACHS. September 2022;6(3):858-862. doi:10.30621/jbachs.1101524
Chicago Efe, Hande, Özge Uysal Yoca, Umut Özerk Önkol, and Zeynep Yuce. “Tescalcin over-Expression Increases Keratin 18 and 19 in K562 Cells”. Journal of Basic and Clinical Health Sciences 6, no. 3 (September 2022): 858-62. https://doi.org/10.30621/jbachs.1101524.
EndNote Efe H, Uysal Yoca Ö, Önkol UÖ, Yuce Z (September 1, 2022) Tescalcin over-expression increases Keratin 18 and 19 in K562 cells. Journal of Basic and Clinical Health Sciences 6 3 858–862.
IEEE H. Efe, Ö. Uysal Yoca, U. Ö. Önkol, and Z. Yuce, “Tescalcin over-expression increases Keratin 18 and 19 in K562 cells”, JBACHS, vol. 6, no. 3, pp. 858–862, 2022, doi: 10.30621/jbachs.1101524.
ISNAD Efe, Hande et al. “Tescalcin over-Expression Increases Keratin 18 and 19 in K562 Cells”. Journal of Basic and Clinical Health Sciences 6/3 (September 2022), 858-862. https://doi.org/10.30621/jbachs.1101524.
JAMA Efe H, Uysal Yoca Ö, Önkol UÖ, Yuce Z. Tescalcin over-expression increases Keratin 18 and 19 in K562 cells. JBACHS. 2022;6:858–862.
MLA Efe, Hande et al. “Tescalcin over-Expression Increases Keratin 18 and 19 in K562 Cells”. Journal of Basic and Clinical Health Sciences, vol. 6, no. 3, 2022, pp. 858-62, doi:10.30621/jbachs.1101524.
Vancouver Efe H, Uysal Yoca Ö, Önkol UÖ, Yuce Z. Tescalcin over-expression increases Keratin 18 and 19 in K562 cells. JBACHS. 2022;6(3):858-62.